| scholarly article | Q13442814 |
| P2093 | author name string | Naír Rodríguez-Hornedo | |
| Yitian M Chen | |||
| P2860 | cites work | Physiological parameters for oral delivery and in vitro testing | Q27687044 |
| A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability | Q28293773 | ||
| Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population | Q28547010 | ||
| Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs | Q33748142 | ||
| In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs | Q34061188 | ||
| Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract | Q34190317 | ||
| The influence of gastric acidity on the bio-availability of ketoconazole | Q34708079 | ||
| Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? | Q34976310 | ||
| Impairing effect of food on ketoconazole absorption | Q35675648 | ||
| Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization | Q36666790 | ||
| Salt formation to improve drug solubility | Q36873893 | ||
| How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability | Q36970866 | ||
| Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5 | Q37013110 | ||
| Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents | Q37415146 | ||
| Physical stability of salts of weak bases in the solid-state | Q37849705 | ||
| Pharmaceutical cocrystals and poorly soluble drugs. | Q38064634 | ||
| Salt disproportionation: A material science perspective | Q39120656 | ||
| Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media | Q40648419 | ||
| Characteristics and significance of the amorphous state in pharmaceutical systems | Q41323277 | ||
| Alterations in gastric acidity in patients infected with human immunodeficiency virus | Q45769106 | ||
| pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model | Q46397050 | ||
| Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds | Q46490440 | ||
| Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update | Q47779125 | ||
| Salt Stability - The Effect of pHmax on Salt to Free Base Conversion. | Q50931533 | ||
| Stability of pharmaceutical salts in solid oral dosage forms. | Q50968375 | ||
| pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media. | Q51336621 | ||
| Upper gastrointestinal (GI) pH in young, healthy men and women. | Q51615125 | ||
| Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs | Q59237519 | ||
| Reaction crystallization of pharmaceutical molecular complexes | Q83913212 | ||
| Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization | Q84936529 | ||
| P433 | issue | 3 | |
| P921 | main subject | cocrystal | Q5139913 |
| P304 | page(s) | 1358-1366 | |
| P577 | publication date | 2018-02-14 | |
| P1433 | published in | Crystal Growth & Design | Q3005997 |
| P1476 | title | Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug. | |
| P478 | volume | 18 |
| Q92282236 | Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers |
| Q57065319 | Mechanistic Analysis Of Co-Crystal Dissolution, Surface Ph, And Dissolution Advantage As A Guide For Rational Selection |
| Q47621793 | Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities |
Search more.